StonvexLoading…
StonvexStonvexStonvexCore line items from ADCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $20.03M | $51.24M | $35.49M | $17.40M |
Operating Income | $-25.25M | $-103.58M | $-72.61M | $-28.46M |
Net Income | $-32.97M | $-136.21M | $-95.25M | $-38.60M |
EPS (Diluted) | $-0.21 | $-1.14 | $-0.86 | $-0.36 |
Total Assets | $291.50M | $289.76M | $321.56M | $272.54M |
Total Liabilities | $507.87M | $527.94M | $520.75M | $510.76M |
Cash & Equivalents | $231.01M | $234.74M | $264.56M | $194.70M |
Free Cash Flow OCF − CapEx | $-29.74M | $-110.31M | $-80.69M | $-56.60M |
Shares Outstanding | 127.17M | 112.63M | 112.50M | 99.18M |